NEWARK, Del., September 10, 2026 — The global Lung Cancer Diagnostics Market is entering a period of structural expansion as molecular testing, liquid biopsy, low-dose CT screening, and biomarker-driven treatment pathways reshape how lung cancer is detected and characterized. The market was valued at USD 13.30 billion in 2025, is projected to reach USD 14.30 billion in 2026, and is...
Bangla